Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP556624.RAUQq5kpp-qmEYl2VUC0_f1M38vqC1hFkHqTCQukgPxDM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP556624.RAUQq5kpp-qmEYl2VUC0_f1M38vqC1hFkHqTCQukgPxDM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP556624.RAUQq5kpp-qmEYl2VUC0_f1M38vqC1hFkHqTCQukgPxDM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP556624.RAUQq5kpp-qmEYl2VUC0_f1M38vqC1hFkHqTCQukgPxDM130_provenance.
- NP556624.RAUQq5kpp-qmEYl2VUC0_f1M38vqC1hFkHqTCQukgPxDM130_assertion description "[Treatment of human ACHN renal cell carcinoma (RCC) and A375 melanoma cells with the DNA demethylating nucleoside analog 5-AZA-2'-deoxycytidine (5-AZA-dC) synergistically augmented antiproliferative effects of IFN- alpha (alpha) 2 and IFN-beta (beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556624.RAUQq5kpp-qmEYl2VUC0_f1M38vqC1hFkHqTCQukgPxDM130_provenance.
- NP556624.RAUQq5kpp-qmEYl2VUC0_f1M38vqC1hFkHqTCQukgPxDM130_assertion evidence source_evidence_literature NP556624.RAUQq5kpp-qmEYl2VUC0_f1M38vqC1hFkHqTCQukgPxDM130_provenance.
- NP556624.RAUQq5kpp-qmEYl2VUC0_f1M38vqC1hFkHqTCQukgPxDM130_assertion SIO_000772 16801630 NP556624.RAUQq5kpp-qmEYl2VUC0_f1M38vqC1hFkHqTCQukgPxDM130_provenance.
- NP556624.RAUQq5kpp-qmEYl2VUC0_f1M38vqC1hFkHqTCQukgPxDM130_assertion wasDerivedFrom befree-2016 NP556624.RAUQq5kpp-qmEYl2VUC0_f1M38vqC1hFkHqTCQukgPxDM130_provenance.
- NP556624.RAUQq5kpp-qmEYl2VUC0_f1M38vqC1hFkHqTCQukgPxDM130_assertion wasGeneratedBy ECO_0000203 NP556624.RAUQq5kpp-qmEYl2VUC0_f1M38vqC1hFkHqTCQukgPxDM130_provenance.
- befree-2016 importedOn "2016-02-19" NP556624.RAUQq5kpp-qmEYl2VUC0_f1M38vqC1hFkHqTCQukgPxDM130_provenance.